sales@businessmarketinsights.com   UK: +442030260021  , US: +16467917070  , Toll Free: 1800 121 6455
Biotechnology North America Liquid Biopsy Market...

North America Liquid Biopsy Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product & Services (Equipment, Reagents & Kits and Services); Sample (Blood Based, Urine Based and Other samples); Circulating Biomarker (Circulating Tumor Cells (CTC), Exosomes and Free Nucleic Acid); Application (Noninvasive Prenatal Testing (NIPT), Oncology, Transplant Diagnostics and Other Applications); End User (Academic & Research Institutes, Hospitals, Reference Laboratories and Other End Users); and, Country

TIPRE00013010 | Pages: 143 | Biotechnology | Aug 2020 | Type: Regional | Status: Published

Market Introduction

Liquid biopsy is a revolutionary technology that is opening up various perspectives. The technology consists of isolation and detection of circulating tumor cells, circulating tumor DNA and exosomes, which provides genomic information of the cancer patients. Liquid biopsy are used in cancer diagnosis in order to study response or resistance to given treatments.

Moreover, in the United States, due to an increasing number of infected patients, healthcare professionals and leading organizations are distracting the flow of healthcare resources from research & development to primary care, which is slowing down the process of innovation. Furthermore, the pandemic spread is also preventing the clinical trials, drug development, and diagnostic industry in the US. For instance, California-based Lucence Diagnostics Pte Ltd., who develops liquid biopsy and has a known player in this industry, has been diverted now to manufacture kits for COVID-19.


Get more information on this report :



Market Overview and Dynamics

The North America liquid biopsy market is expected to reach US$ 3,531.44 Mn in 2027 from US$ 1,522.58 Mn in 2018. The market is anticipated to grow with a CAGR of 10.1% from 2019-2027. Factors driving the market growth include increasing prevalence of cancer. However, low sensitivity of liquid biopsy is likely to have a negative impact on market growth.

Key Market Segments

By product & services, the reagents and kits segment accounted for the largest market share in the North American liquid biopsy market in 2018. In terms of sample, the blood based segment held the largest market share of the liquid biopsy market by 2027. By circulating biomarker, the circulating tumor cells (CTC) segment accounted for the largest market share in the North American liquid biopsy market in 2019. By 2027, the oncology segment accounted for the largest market share by application. Furthermore, in terms of end user, the reference laboratories segment held the largest market share of the liquid biopsy market by 2027.

Major Sources and Companies Listed

Some of the major primary and secondary sources for liquid biopsy market included in the report are, American Cancer Society (ACR), Centers For Disease Control And Prevention (CDC), Food and Drug Administration (FDA), International Diabetes Federation (IDF), and among others.

Reasons to buy the report

  • To understand the liquid biopsy market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for liquid biopsy market
  • Efficiently plan M&A and partnership deals in liquid biopsy market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form liquid biopsy market
  • Obtain market revenue forecast for market by various segments from 2018-2027 in North America region.

 

NORTH AMERICA LIQUID BIOPSY MARKET SEGMENTATION

By Product & Service

  • Equipment
  • Reagents & Kits
  • Services

By Sample

  • Blood Based
  • Urine Based
  • Other samples

By Circulating Biomarker

  • Circulating Tumor Cells (CTC)
  • Exosomes
  • Free Nucleic Acid

By Application

  • Noninvasive Prenatal Testing (NIPT)
  • Oncology
  • Transplant Diagnostics
  • Other Applications

By End User

  • Academic & Research Institutes
  • Hospitals
  • Reference Laboratories
  • Other End Users

By Geography

•             North America

  • US
  • Canada
  • Mexico

Company Profiles

  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories Inc.
  • Exact Sciences Corporation
  • Biocept, Inc
  • Inivata Ltd

1.          Introduction

1.1        Scope of the Study

1.2        The Insight Partners Research Report Guidance

1.3        Market Segmentation

1.3.1        North America Liquid Biopsy Market – By Product & Service

1.3.2        North America Liquid Biopsy Market – By Sample

1.3.3        North America Liquid Biopsy Market – By Circulating Biomarker

1.3.4        North America Liquid Biopsy Market – By Application

1.3.5        North America Liquid Biopsy Market – By End User

1.3.6        North America Liquid Biopsy Market – By Country

2.          North America Liquid Biopsy Market – Key Takeaways

3.          Research Methodology

3.1        Coverage

3.2        Secondary Research

3.3        Primary Research

4.          North America Liquid Biopsy Market Landscape

4.1        Overview

4.2        PEST Analysis

4.2.1        North America Liquid Biopsy Market - North America PEST Analysis

4.3        Expert Opinion

5.          North America Liquid Biopsy - Key Market Dynamics

5.1        Key Market Drivers

5.1.1        Increasing Prevalence of Cancer

5.2        Key Restraints

5.2.1        Low Sensitivity of Liquid Biopsy

5.3        Key Market Opportunities

5.3.1        Increasing Liquid Biopsy Due to Growing Application and Advancements

5.4        Future Trends

5.4.1        Consistent Launch of New Products

5.5        Impact Analysis

6.          Liquid Biopsy Market – North America Analysis

6.1        North America Liquid Biopsy Market Revenue Forecasts and Analysis

7.          Liquid Biopsy Market Analysis – By Product & Services

7.1        Overview

7.2        Liquid Biopsy Market Revenue Share, by Product& Service (2019 and 2027)

7.3        Equipment

7.3.1        Overview

7.4        Equipment: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

7.5        Reagents & Kits

7.5.1        Overview

7.5.2        Reagents & Kits: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

7.6        Services

7.6.1        Overview

7.6.2        Services: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

8.          Liquid Biopsy Market Analysis – By Sample

8.1        Overview

8.2        Liquid Biopsy Market, by Sample, 2019 and 2027 (%)

8.3        Blood Based

8.3.1        Overview

8.3.2        Blood Based: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

8.4        Urine Based

8.4.1        Overview

8.4.2        Urine Based: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

8.5        Other Samples

8.5.1        Overview

8.6        Other Samples: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

9.          Liquid Biopsy Market Analysis – By Circulating Biomarker

9.1        Overview

9.2        Liquid Biopsy Market, by Circulating Biomarker, 2019 and 2027 (%)

9.3        Circulating Tumor Cells (CTC)

9.3.1        Overview

9.3.2        Circulating Tumor Cell (CTC): Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

9.4        Exosomes

9.4.1        Overview

9.4.2        Exosomes: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

9.5        Free Nucleic Acid

9.5.1        Overview

9.6        Free Nucleic Acid: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

10.       Liquid Biopsy Market Analysis – By Application

10.1      Overview

10.2      Liquid Biopsy Market, by Application, 2019 and 2027 (%)

10.3      Non-invasive Prenatal Testing (NIPT)

10.3.1     Overview

10.3.2     Noninvasive prenatal testing (NIPT): Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

10.4      Oncology

10.4.1     Overview

10.4.2     Oncology: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

10.5      Transplant Diagnostics

10.5.1     Overview

10.5.2     Transplant Diagnostics: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

10.6      Other Applications

10.6.1     Overview

10.7      Other applications: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

11.       Liquid Biopsy Market Analysis – By End User

11.1      Overview

11.2      Liquid Biopsy Market, by End-User, 2019 and 2027 (%)

11.3      Academic & Research Institutes

11.3.1     Overview

11.3.2     Academic & Research Institutes: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

11.4      Hospitals

11.4.1     Overview

11.4.2     Hospitals: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

11.5      Reference Laboratories

11.5.1     Overview

11.6      Reference Laboratories: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

11.7      Other End Users

11.7.1     Overview

11.8      Other End Users: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

12.       Liquid Biopsy Market Revenue and Forecasts To 2027 – Geographical Analysis

12.1      North America Liquid Biopsy Market Revenue and Forecasts To 2027

12.1.1     Overview

12.1.2     North America: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.1.3     North America: Liquid Biopsy Market, by Product & Service, 2018–2027 (USD Million)

12.1.4     North America: Liquid Biopsy Market, by Sample, 2018–2027 (USD Million)

12.1.5     North America: Liquid Biopsy Market, by Circulating Biomarker, 2018–2027 (USD Million)

12.1.6     North America: Liquid Biopsy Market, by Application, 2018–2027 (USD Million)

12.1.7     North America: Liquid Biopsy Market, by End User, 2018–2027 (USD Million)

12.1.8     North America: Liquid Biopsy Market, by Country, 2019 & 2027 (%)

12.1.9     US: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.1.9.1       US: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.1.9.2       US: Liquid Biopsy Market, by Product & Service, 2018–2027 (USD Million)

12.1.9.3       US: Liquid Biopsy Market, by Sample, 2018–2027 (USD Million)

12.1.9.4       US: Liquid Biopsy Market, by Circulating Biomarker, 2018–2027 (USD Million)

12.1.9.5       US: Liquid Biopsy Market, by Application, 2018–2027 (USD Million)

12.1.9.6       US: Liquid Biopsy Market, by End User, 2018–2027 (USD Million)

12.1.10   Canada: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.1.10.1    Canada: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.1.10.2    Canada: Liquid Biopsy Market, by Product & Service, 2018–2027 (USD Million)

12.1.10.3    Canada: Liquid Biopsy Market, by Sample, 2018–2027 (USD Million)

12.1.10.4    Canada: Liquid Biopsy Market, by Circulating Biomarker, 2018–2027 (USD Million)

12.1.10.5    Canada: Liquid Biopsy Market, by Application, 2018–2027 (USD Million)

12.1.10.6    Canada: Liquid Biopsy Market, by End User, 2018–2027 (USD Million)

12.1.11   Mexico: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.1.11.1    Mexico: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

12.1.11.2    Mexico: Liquid Biopsy Market, by Product & Service, 2018–2027 (USD Million)

12.1.11.3    Mexico: Liquid Biopsy Market, by Sample, 2018–2027 (USD Million)

12.1.11.4    Mexico: Liquid Biopsy Market, by Circulating Biomarker, 2018–2027 (USD Million)

12.1.11.5    Mexico: Liquid Biopsy Market, by Application, 2018–2027 (USD Million)

12.1.11.6    Mexico: Liquid Biopsy Market, by End User, 2018–2027 (USD Million)

13.       Impact of COVID-19 Pandemic on Global Liquid Biopsy Market

13.1      North America: Impact Assessment of COVID-19 Pandemic

14.       Company Profiles

14.1      Thermo Fisher Scientific Inc.

14.1.1     Key Facts

14.1.2     Business Description

14.1.3     Products and Services

14.1.4     Financial Overview

14.1.5     SWOT Analysis

14.1.6     Key Developments

14.2      Bio-Rad Laboratories Inc.

14.2.1     Key Facts

14.2.2     Business Description

14.2.3     Products and Services

14.2.4     Financial Overview

14.2.5     SWOT Analysis

14.2.6     Key Developments

14.3      Exact Sciences Corporation

14.3.1     Key Facts

14.3.2     Business Description

14.3.3     Products and Services

14.3.4     Financial Overview

14.3.5     SWOT Analysis

14.3.6     ey Developments

14.4      Biocept, Inc.

14.4.1     Key Facts

14.4.2     Business Description

14.4.3     Products and Services

14.4.4     Financial Overview

14.4.5     SWOT Analysis

14.4.6     Key Developments

14.5      Inivata Ltd

14.5.1     Key Facts

14.5.2     Business Description

14.5.3     Products and Services

14.5.4     Financial Overview

14.5.5     SWOT Analysis

14.5.6     Key Developments

15.       Appendix

15.1      About The Insight Partners

15.2      Glossary of Terms

 

LIST OF TABLES

Table 1.            North America Liquid Biopsy Market, by Product & Service– Revenue and Forecast to 2027 (USD Million)

Table 2.            North America Liquid Biopsy Market, by Sample – Revenue and Forecast to 2027 (USD Million)

Table 3.            North America Liquid Biopsy Market, by Circulating Biomarker – Revenue and Forecast to 2027 (USD Million)

Table 4.            North America Liquid Biopsy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 5.            North America Liquid Biopsy Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 6.            Estimated Number of New Cancer Cases and Deaths, US, 2020

Table 7.            US Liquid Biopsy Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)

Table 8.            US Liquid Biopsy Market, by Sample – Revenue and Forecast to 2027 (USD Million)

Table 9.            US Liquid Biopsy Market, by Circulating Biomarker – Revenue and Forecast to 2027 (USD Million)

Table 10.          US Liquid Biopsy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 11.          US Liquid Biopsy Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 12.          Canada Liquid Biopsy Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)

Table 13.          Canada Liquid Biopsy Market, by Sample – Revenue and Forecast to 2027 (USD Million)

Table 14.          Canada Liquid Biopsy Market, by Circulating Biomarker – Revenue and Forecast to 2027 (USD Million)

Table 15.          Canada Liquid Biopsy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 16.          Canada Liquid Biopsy Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 17.          Mexico Incidence, Mortality and Prevalence by cancer site in 2018

Table 18.          Mexico Liquid Biopsy Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)

Table 19.          Mexico Liquid Biopsy Market, by Sample – Revenue and Forecast to 2027 (USD Million)

Table 20.          Mexico Liquid Biopsy Market, by Circulating Biomarker – Revenue and Forecast to 2027 (USD Million)

Table 21.          Mexico Liquid Biopsy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 22.          Mexico Liquid Biopsy Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 1.            Glossary of Terms, North America Liquid Biopsy Market

 

LIST OF FIGURES

Figure 1.           Liquid Biopsy Market Segmentation

Figure 2.           North America Liquid Biopsy Market Overview

Figure 3.           Reagents & Kits Segment Held Largest Share Of Product & Services Segment in Liquid Biopsy Market

Figure 4.           US Is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           North America Liquid Biopsy Market- Leading Country Markets (US$ Mn)

Figure 7.           North America Liquid Biopsy Market - North America PEST Analysis

Figure 8.           Liquid Biopsy Market Impact Analysis of Drivers and Restraints

Figure 9.           North America Liquid Biopsy Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 10.        Liquid Biopsy Market Revenue Share, by Product & Service (2019 and 2027)

Figure 11.        Equipment: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 12.        Reagents & Kits: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 13.        Services: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 14.        Liquid Biopsy Market, by Sample, 2019 and 2027 (%)

Figure 15.        Blood Based: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 16.        Urine Based: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 17.        Other Samples: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 18.        Liquid Biopsy Market, by Circulating Biomarker, 2019 and 2027 (%)

Figure 19.        Circulating Tumor Cell (CTC): Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20.        Exosomes: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21.        Free Nucleic Acid: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22.        Liquid Biopsy Market, by Application, 2019 and 2027 (%)

Figure 23.        Noninvasive prenatal testing (NIPT): Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 24.        Oncology: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 25.        Transplant Diagnostics: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 26.        Other applications: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 27.        Liquid Biopsy Market, by End-User, 2019 and 2027 (%)

Figure 28.        Academic & Research Institutes: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 29.        Hospitals: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 30.        Reference Laboratories: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 31.        Other End Users: Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 32.        North America: Liquid Biopsy Market, by Key Country – Revenue (2019) (USD Million)

Figure 33.        North America Liquid Biopsy Market Revenue and Forecast to 2027 (USD Million)

Figure 34.        North America: Liquid Biopsy Market, by Country, 2019 & 2027 (%)

Figure 35.        US: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

Figure 36.        Canada: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

Figure 37.        Mexico: Liquid Biopsy Market – Revenue and Forecast to 2027 (USD Million)

Figure 38.        Impact of COVID-19 Pandemic In North American Country Markets

  1. Thermo Fisher Scientific Inc.
  2. Bio-Rad Laboratories Inc.
  3. Exact Sciences Corporation
  4. Biocept, Inc
  5. Inivata Ltd
  • To understand the liquid biopsy market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for liquid biopsy market
  • Efficiently plan M&A and partnership deals in liquid biopsy market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form liquid biopsy market
  • Obtain market revenue forecast for market by various segments from 2018-2027 in North America region.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports
Report Name Published Date
North America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a.. May 2022
North America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Ele.. May 2022
North America Cabinet LED Lighting Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (In-cabinet Lighting and Under-Cabinet Ligh.. May 2022
Purchase Options
Single User License
$3000
$1500
Site License
$4000
$2000
Enterprise License
$5000
$2500
GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount
Subscription Member Price: FREE
Get Subscription